Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin (Q44461718)

3 December 2017

Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin (English)

1 reference

3 December 2017

0 references

3

Edwin D Boudreaux

1 reference

3 December 2017

8

Carlos A Camargo

1 reference

3 December 2017

7

Sunday Clark

1 reference

3 December 2017

Ian Colman

4

0 references

author name string

Brian H Rowe

1

1 reference

3 December 2017

Sam G Campbell

2

1 reference

3 December 2017

Riyad B Abu-Laban

5

1 reference

3 December 2017

Marco L A Sivilotti

6

1 reference

3 December 2017

3 May 2007

1 reference

Academic Emergency Medicine

3 December 2017

1 reference

3 December 2017

14

1 reference

3 December 2017

7

1 reference

3 December 2017

607-615

1 reference

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

3 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1553-2712.2007.TB01844.X

10.1111/J.1553-2712.2007.TB01844.X

21 January 2018

Identifiers

DOI

1 reference

release_l5z34uhbcbedzet2bg5bsmkbda

3 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l5z34uhbcbedzet2bg5bsmkbda

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference